← All organizations

Bayer

For profitContributed to NMEWebsite ↗

Also known as: Bayer | BAYER | Bayer AG (Sponsor) | Bayer (collaborator) | BAYER HEALTHCARE | Bayer HealthCare LLC | BAYER HEALTHCARE LLC | Bayer HealthCare Pharmaceuticals Inc. | Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma | BAYER HEALTHCARE PHARMS | BAYER HLTHCARE | Bayer/Onyx | BAYER PHARMS | BAYER S.p.A. - Italia | Bayer University Kano, Nigeria | Bayer (v1) | Bayer (v2) | Bayer Yakuhin, Ltd. | University of Goettingen, Section Neurobiology (Head: Prof. Dr. T. Bayer), Germany

Highest phase reached

Phase 4

First clinical trial

Dec 31, 1899

First marketed drug

Sep 15, 1949

First NDA

Jun 25, 1965

Last known activity

May 1, 2026

Timeline

1860s

  1. Jan 1, 1863

    Bayer— Founded

1970s

  1. Apr 30, 1976

    aluminum acetate— Marketing Organization

  2. Jan 1, 1979

    Miles— Acquired

1990s

  1. Jan 1, 1995

    Corporación Bonima S.A. de C.V.— Acquired

  2. Dec 10, 1999

    moxifloxacin— NDA Organization

2000s

  1. Dec 7, 2001

    butenafine— NDA Secondary Org

  2. Jan 1, 2009

    Schering AG— Acquired

2010s

  1. Dec 19, 2013

    Algeta ASA— Acquired

2020s

  1. Aug 11, 2020

    NeRRe Therapeutics Ltd.— Acquired

  2. Oct 26, 2020

    Asklepios BIoPharmaceutical— Acquired

  3. Jun 3, 2021

    Noria Therapeutics— Acquired

  4. Jun 3, 2021

    PSMA Development Corp, LLCPSMA Development Corp, LLC— Acquired

  5. Aug 5, 2021

    Vividion Therapeutics— Acquired

  6. Aug 12, 2025

    Kumquat Biosciences Inc.— Acquired

Drugs by trial phase (557 distinct, 1660 trials)

Indications

Studied for

Marketed drugs (78)

Subsidiaries (10 direct, 14 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Barmen, DE Jan 1, 1863
First NDA
Jun 25, 1965
Last known activity
May 1, 2026

Designations held

  • Orphan drug
  • Fast track
  • Priority review
  • Accelerated approval

Notes

1918- American assets of The Bayer Company acquired by Sterling Products Company